Assertio Holdings Regains Nasdaq Minimum Bid Price Compliance
ASRT sits 21% above its 52-week low of $7.706.
Summary
Assertio Holdings, Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement, resolving a previous listing deficiency and removing the threat of delisting.
Key Events · Corporate Governance and Compliance · ASRT
-
Nasdaq Compliance Regained
The company received notification from Nasdaq that it has satisfied the minimum bid price requirement under Listing Rule 5550(a)(2).
-
Delisting Risk Removed
This resolution closes the matter, ensuring the company's continued listing on the Nasdaq Capital Market.
Analysis · ASRT · Life Sciences
Assertio Holdings, Inc. has successfully resolved its non-compliance with Nasdaq's minimum bid price requirement. This is a significant positive development as it removes the immediate threat of delisting, which can severely impact a company's liquidity and investor confidence. For a company of this size, maintaining its exchange listing is crucial for access to capital markets and visibility. The resolution of this issue provides stability and removes a key overhang for investors.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ASRT was trading at $9.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $59.8M. The 52-week trading range was $7.71 to $15.15. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.